MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. - Wikidata - awgldk - TriplyDB

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

http://www.wikidata.org/entity/Q42279835

about

A comprehensive overview of radioguided surgery using gamma detection probe technology Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma Carbonic anhydrase isozymes IX and XII in gastric tumors Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer Molecular diagnosis and therapy of kidney cancer.A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody molecule The next generation of positron emission tomography radiopharmaceuticals in oncology.Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.Causes and consequences of DNA hypomethylation in human cancer.Hypoxia and angiogenesis in pancreatic cancer.CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding.The role of molecular markers in the staging of renal cell carcinoma.Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.Novel therapies in genitourinary cancer: an update.Radiolabeled antibodies in renal cell carcinoma.Antibody therapy in renal cell carcinoma.Carbonic anhydrase IX: historical and future perspectives.Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant.Crossing paths in Human Renal Cell Carcinoma (hRCC).Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.Immunostimulatory activity of dendritic cells pulsed with carbonic anhydrase IX and Acinetobacter baumannii outer membrane protein A for renal cell carcinoma.Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma.Transcriptional response to hypoxia in human tumors.Expression of carbonic anhydrase IX in human pancreatic cancer.Redox state and carbonic anhydrase isozyme IX expression in human renal cell carcinoma: biochemical and morphological investigations.Pretreatment with interferon-alpha2a modulates perioperative immunodysfunction in patients with renal cell carcinoma.Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients.Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2.

P2860

Q21245578-008B1DA3-70D1-4FA8-89BF-ED2517B984B7 Q27026961-4731F907-0A51-4425-AED4-9CE45DE9F449 Q28186386-25924FB7-5B20-439E-A618-51434B2200EC Q33484460-510049B5-AE84-4DC3-8DA1-445F5B1DABD0 Q34065685-9BEACBEA-DDC6-4095-9D68-648E457C3B1C Q34111701-F2551448-F537-49F5-B623-3ECBF532768E Q34111751-203A708F-9B57-4929-9F78-EE2490BFB3E7 Q34775811-BC338897-14B8-43E2-8AC1-1585DD76E1E0 Q35525690-F2587C0A-10B4-4EBA-8B3F-905D655DCA92 Q35746400-015C436F-AECD-4832-AA6E-94C60CA02307 Q36164751-021AD1B6-7BC8-4286-A4AE-BAACB60F985A Q36572752-DAC9580E-9E99-4161-9F85-012549AE73B5 Q36612144-5D57F8C4-3EED-4C6C-93EE-ABC2C017762E Q36794752-58D02D19-4AA7-435F-9F5F-3838C50E472F Q36842777-E3E88907-D372-46C1-89CB-B459851E9B2A Q36856612-D22D12EE-1937-4D5F-83A4-EE71AFBB61A1 Q37022628-5E921DE3-CE13-4801-8D78-6E458AAA364A Q37073600-9B824EB6-61DB-4565-9A4F-D1B750006CCD Q37145154-34E26432-C035-4754-884D-2706345FB18B Q37177275-942169CD-801A-4D16-9C95-6A10288555E6 Q38064316-2A624AA2-4645-439C-A7D2-7F1446FAA184 Q38431510-3BF63B02-E8EB-494A-A053-12615ABD3B1B Q38467824-BE7775C3-605B-486C-8524-6CF98DBB398A Q38476561-5C7E604B-8D16-4347-9EED-0A2E9BA4FEF7 Q40551014-7B61D250-5693-4AD3-8CD4-DBE39F918A1C Q40786039-8DCF08A5-54CA-4F8E-A66C-DFB52F84AD2B Q43727979-7F992D2B-D48A-4ACA-877A-2DF4338158B4 Q44611997-A9FA90E0-7F0D-4B74-8538-F426A315A31C Q45120202-8615624E-09D2-4ED5-A354-1C9D68D2D092 Q46758739-1C5AD7E9-95DA-4B72-B853-9D8ED4C058F9 Q47109274-0C037815-5437-49BF-90DA-8638F33541FB Q47376009-D5BE9118-757E-4249-AA37-BDC9CC4F7278 Q53388568-13070918-599E-41D9-8DC7-A39DFC230353

P2860

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

http://www.wikidata.org/entity/Q42279835

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

@en

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

@nl

type

label

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

@en

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

@nl

prefLabel

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

@en

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

@nl

P1433

Q42279835-888C26C1-7275-421F-B073-DD80D03A3AAA

P1476

Q42279835-13CF47A5-249E-4BD9-994B-154A31A3B1CB

P2093

Q42279835-2AC1ED3B-7740-45FD-8D7D-62CA1B45D751

Q42279835-8506C2E3-2C78-402B-A677-A58C1EAEE610

Q42279835-9F2AA61D-6BA1-4F80-ABBB-A6F1C338303D

Q42279835-AD99B301-31CE-4107-A675-4C6C8B51491F

Q42279835-B34D11D6-2591-44C7-A413-AD898CEECF31

Q42279835-B65FA7D1-2A8F-46C0-9705-3E3E80AF0149

Q42279835-F6E24411-2FE6-4573-B472-BFECC24A7EDF

P2860

Q42279835-010B85D9-2273-4E4E-BCB2-272D4466ED38

Q42279835-0E8C8585-5594-4E89-991B-4F2E5930A79A

Q42279835-1BD925A9-333A-44AB-AA60-CDB74BB22835

Q42279835-511A1316-564A-4603-BF5B-929DC1D2936B

Q42279835-5A487045-4AC3-46CA-9D03-001241DEB5B5

Q42279835-8A98FA82-384A-401B-8670-5EF5F6FACDE5

Q42279835-A03E7D44-F2C8-44E4-A045-BC9892DDE322

Q42279835-BBE709BA-4A30-417A-808D-21F5004E9534

Q42279835-C0E54958-D60C-4696-BBAF-6478B542E20B

Q42279835-C3229FC4-6F8E-4F93-AF23-2B7EC16E5546

P2888

Q42279835-9B3F4F41-F3E5-45BA-B347-0481E71A0C3D

P304

Q42279835-CDDB8C47-2C68-4A5A-9C11-9146CFE5A22D

P31

Q42279835-7CA900B4-1DA5-41A8-ACE7-F2C3A6DAFE90

P356

Q42279835-A90C6A59-D1A1-4247-9A89-EEEAA001AAAB

P407

Q42279835-D747D5AB-D1EF-4665-8690-66537A256217

P433

Q42279835-72B3B535-9DBE-4A48-A8E9-18614F95EF1C

P478

Q42279835-5E4E6F03-38FD-4D2C-8BE2-5CBD4C50A23F

P577

Q42279835-979ED942-AA60-42FF-899D-F95816DC219C

P5875

Q42279835-A1E46FAE-FA2A-4CC8-B619-AC853F7390CE

P698

Q42279835-F4126E69-6897-4C33-9D2A-93749B12DEB6

P921

Q42279835-06925DA3-0DA8-4486-BB7C-58D95FE71478

P932

Q42279835-BC34F22C-F8F3-4998-ABC6-5522EEC851B7

P356

P1433

British Journal of Cancer

P1476

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

@en

P2093

E Oosterwijk

http://www.w3.org/2001/XMLSchema#string

H Uemura

http://www.w3.org/2001/XMLSchema#string

K Yoshida

http://www.w3.org/2001/XMLSchema#string

K Yoshikawa

http://www.w3.org/2001/XMLSchema#string

S Saga

http://www.w3.org/2001/XMLSchema#string

Y Hirao

http://www.w3.org/2001/XMLSchema#string

Y Nakagawa

http://www.w3.org/2001/XMLSchema#string

P2860

Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes

Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships

Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment

Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts

Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma.

Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma

Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas.

A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN.

The natural history and clinical features of renal carcinoma.

Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation.

P2888

P304

741-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6690757

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

1999-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12727507

http://www.w3.org/2001/XMLSchema#string

P698

10574265

http://www.w3.org/2001/XMLSchema#string

P921

P932

2362900

http://www.w3.org/2001/XMLSchema#string